Overactivity of the hexosamine pathway mediates glucose-induced insulin resistance in rat adipocytes. Glutamine:fructose-6-phosphate amidotransferase (GFA) is the rate-limiting enzyme of this pathway. We determined GFA activity in human skeletal muscle biopsies and rates of insulin-stimulated whole-body, oxidative, and nonoxidative glucose disposal using the euglycemic insulin clamp technique combined with indirect calorimetry (insulin infusion rate (1.5 mU · kg−1 · min−1) in 12 male patients with NIDDM (age 54 ± 2 years, BMI 27.5 ± 0.9 kg/m2, fasting plasma glucose 8.5 ± 0.6 mmol/l) and 9 matched normal men. GFA activity was detectable in human skeletal muscles and completely inhibited by uridine-5′-diphospho-N-acetylglucosamine (UDP-GlcNAc) in all subjects. GFA activity was 46% increased in the NIDDM patients compared with the normal subjects (9.5 ± 1.3 vs. 6.5 ± 1.2 pmol, P < 0.05). Whole-body glucose uptake was 58% decreased in patients with NIDDM (20 ± 3 μmol · kg body wt−1 · min−1) compared with normal subjects (47 ± 4 μmol · kg body wt−1 · min−1 P < 0.001). This decrease was attributable to decreases in both glucose oxidation (9 ± 1 vs. 15 ± 1 μmol · kg−1 · min−1, NIDDM patients vs. control subjects, P < 0.002) and nonoxidative glucose disposal (11 ± 2 vs. 31 ± 4 μmol · kg−1 · min−1 P < 0.001). In patients with NIDDM, both HbA1c (r = 0.51, P < 0.05) and BMI (r = −0.57, P < 0.05) correlated with whole-body glucose uptake. HbA1c but not BMI or insulin sensitivity was correlated with basal GFA activity (r = −0.57,P < 0.01) in NIDDM patients and control subjects. We conclude that GFA is found in human skeletal muscle and that all this activity is sensitive to feedback inhibition by UDP-GlcNAc. Chronic hyperglycemia is associated with an increase in skeletal muscle GFA activity, suggesting that increased activity of the hexosamine pathway may contribute to glucose toxicity and insulin resistance in humans.
Skip Nav Destination
Article navigation
Original Articles|
March 01 1996
Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM
Hannele Yki-Järvinen;
Hannele Yki-Järvinen
The University of Texas Health Science Center at San Antonio San Antonio, Texas
Helsinki, Finland
Search for other works by this author on:
Marc C Daniels;
Marc C Daniels
The University of Mississippi Medical Center and Veterans Administration Medical Center Jackson
Mississippi
Search for other works by this author on:
Antti Virkamäki;
Antti Virkamäki
Department of Medicine The University of Helsinki
Helsinki, Finland
Search for other works by this author on:
Sari Mäkimattila;
Sari Mäkimattila
Department of Medicine The University of Helsinki
Helsinki, Finland
Search for other works by this author on:
Ralph A DeFronzo;
Ralph A DeFronzo
The University of Texas Health Science Center at San Antonio San Antonio, Texas
Helsinki, Finland
Search for other works by this author on:
Don McClain
Don McClain
The University of Mississippi Medical Center and Veterans Administration Medical Center Jackson
Mississippi
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Hannele Yki-Jarvinen, The University of Texas Health Science Center at San Antonio, Department of Medicine, Division of Diabetes, 7703 Floyd Curl Dr., San Antonio, TX 78284.
Diabetes 1996;45(3):302–307
Article history
Received:
May 30 1995
Received:
October 26 1995
Accepted:
October 26 1995
PubMed:
8593934
Citation
Hannele Yki-Järvinen, Marc C Daniels, Antti Virkamäki, Sari Mäkimattila, Ralph A DeFronzo, Don McClain; Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM. Diabetes 1 March 1996; 45 (3): 302–307. https://doi.org/10.2337/diab.45.3.302
Download citation file:
141
Views